2Mas A. Hepatie eneephalopathy:from pathophysiology to treament. digestion,2006,73 ( suppl 1) :86-93.
3Lizardi C J, Almeda P, Guevara L, et al. Hepatic encephal-pathy. Ann Hepatol,2003,2 (3) : 122-130.
4Jain L, Sharma BC, Sharma P, et al. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis, 2012, 44: 1027-1031.
5Parker T, Freilich S, Tidswell T, et al. Hepatic encephalopathy with epilepsia partialis continua: a case report. Seizure, 2012, 21: 813-815.
6Seo YS, Vim SY, Jung JY, et al. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterology Hepatol, 2012, 27: 1695-1704.
7Corbett C, Mangat K, Olliff S, et al. The role of Transjugular Intrahepatic Portosystemic Stent-Shunt(TIPSS) in the management of variceal hemorrhage. Liver Int, 2012, 32: 1493-1504.
8Zhang LJ, Zheng G, Zhang L, et al. Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: a functional MR imaging study. Radiology, 2012, 265: 528-536.
9Chiu J, Tang YF, Yao TJ, et al. The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits. Cancer, 2012, 118: 5293-5301.
10Kappus MR, Bajaj JS. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol, 2012, 10: 1208-1219.
